Affordable Access

Neuroleptic malignant syndrome during remoxipride treatment. A case report.

Authors
Type
Published Article
Journal
European Neuropsychopharmacology
0924-977X
Publisher
Elsevier
Publication Date
Volume
3
Issue
4
Pages
517–519
Identifiers
PMID: 8111225
Source
Medline
License
Unknown

Abstract

Neuroleptic malignant syndrome (NMS) is a rare, life-threatening complication of neuroleptic treatment. The authors describe a case of NMS during treatment with a new atypical neuroleptic, remoxipride. To their knowledge, there are no previously reported cases.

Statistics

Seen <100 times